Suppr超能文献

西太平洋地区和南非社区获得性呼吸道病原体的抗菌药物耐药性趋势:哨兵抗菌监测计划(1998 - 1999年)报告,包括BMS284756的体外评估

Antimicrobial resistance trends in community-acquired respiratory tract pathogens in the Western Pacific Region and South Africa: report from the SENTRY antimicrobial surveillance program, (1998-1999) including an in vitro evaluation of BMS284756.

作者信息

Bell J M, Turnidge J D, Jones R N

机构信息

, Adelaide, Australia

出版信息

Int J Antimicrob Agents. 2002 Feb;19(2):125-32. doi: 10.1016/s0924-8579(01)00475-7.

Abstract

From 1998 to 1999, a large number of community-acquired respiratory tract isolates of Streptococcus pneumoniae (n=566), Haemophilus influenzae (n=513) and Moraxella catarrhalis (n=228) were collected from 15 centres in Australia, Hong Kong, Japan, China, the Philippines, Singapore, South Africa and Taiwan through the SENTRY Antimicrobial Surveillance Program. Isolates were tested against 26 antimicrobial agents using the NCCLS-recommended methods. Overall, 40% of S. pneumoniae isolates were resistant to penicillin with 18% of strains having high-level resistance (MIC > or =2 mg/l). Rates of erythromycin and clindamycin resistance were 41 and 23%, respectively. Penicillin-resistant strains showed high rates of resistance to other antimicrobial agents: 96% to trimethoprim-sulphamethoxazole (TMP-SMX), 84% to tetracycline and 81% to erythromycin. A significant proportion of penicillin-susceptible strains was also resistant to erythromycin (21%), tetracycline (29%) and TMP-SMZ (26%). Small numbers of strains were resistant to levofloxacin (0.7%), trovafloxacin (0.4%) and grepafloxacin (1.3%) where as all strains remained uniformly susceptible to quinupristin/dalfopristin and BMS284756 (MIC(90), 0.06 mg/l), a new desfluoroquinolone. beta-lactamases were, produced by 20% H. influenzae isolates and only rare strains showed intrinsic resistance to amoxycillin. Other beta-lactam agents showed good activity with rates of resistance less than 2% and all isolates showed susceptibility to cefixime, ceftibuten, cefepime and cefotaxime. Rates of resistance to tetracycline and chloramphenicol were also relatively low at 3%. The majority (98%) of M. catarrhalis isolates was found to be beta-lactamase-positive and resistant to penicillins, however, resistance to erythromycin and tetracycline was also low at 1.8%. Both H. influenzae and M. catarrhalis isolates were uniformly susceptible to the new desfluoroquinolone and tested fluoroquinolones.

摘要

1998年至1999年期间,通过哨兵抗菌监测计划,从澳大利亚、香港、日本、中国、菲律宾、新加坡、南非和台湾的15个中心收集了大量社区获得性呼吸道分离株,其中肺炎链球菌(n = 566)、流感嗜血杆菌(n = 513)和卡他莫拉菌(n = 228)。采用美国国家临床实验室标准委员会(NCCLS)推荐的方法,对分离株进行了26种抗菌药物的检测。总体而言,40%的肺炎链球菌分离株对青霉素耐药,其中18%的菌株具有高水平耐药(最低抑菌浓度[MIC]≥2mg/L)。红霉素和克林霉素的耐药率分别为41%和23%。耐青霉素菌株对其他抗菌药物也表现出较高的耐药率:对复方新诺明(TMP-SMX)的耐药率为96%,对四环素的耐药率为84%,对红霉素的耐药率为81%。相当一部分对青霉素敏感的菌株对红霉素(21%)、四环素(29%)和TMP-SMZ(26%)也耐药。少数菌株对左氧氟沙星(0.7%)、曲伐沙星(0.4%)和格帕沙星(1.3%)耐药,而所有菌株对奎奴普丁/达福普汀和新型去氟喹诺酮类药物BMS284756(MIC90,0.06mg/L)均保持一致敏感。20%的流感嗜血杆菌分离株产生β-内酰胺酶,仅有极少数菌株对阿莫西林表现出固有耐药性。其他β-内酰胺类药物显示出良好的活性,耐药率低于2%,所有分离株对头孢克肟、头孢布烯、头孢吡肟和头孢噻肟均敏感。对四环素和氯霉素的耐药率也相对较低,为3%。发现大多数(98%)卡他莫拉菌分离株为β-内酰胺酶阳性,对青霉素耐药,然而,对红霉素和四环素的耐药率也较低,为1.8%。流感嗜血杆菌和卡他莫拉菌分离株对新型去氟喹诺酮类药物和所检测的氟喹诺酮类药物均保持一致敏感。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验